A detailed history of Two Sigma Securities, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 24,196 shares of ATOS stock, worth $24,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,196
Holding current value
$24,921
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.09 - $1.52 $26,373 - $36,777
24,196 New
24,196 $36,000
Q1 2024

May 15, 2024

BUY
$0.8 - $1.89 $27,663 - $65,354
34,579 New
34,579 $62,000
Q3 2023

Nov 14, 2023

BUY
$0.74 - $1.35 $8,353 - $15,238
11,288 Added 44.83%
36,466 $26,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.28 $15,106 - $32,227
25,178 New
25,178 $31,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $1.01 $195 - $393
390 Added 1.03%
38,428 $20,000
Q3 2022

Nov 14, 2022

BUY
$0.82 - $1.14 $20,732 - $28,822
25,283 Added 198.22%
38,038 $32,000
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.28 $10,841 - $16,326
12,755 New
12,755 $14,000
Q1 2019

May 15, 2019

SELL
$1.11 - $7.07 $13,846 - $88,191
-12,474 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.92 - $1.67 $11,476 - $20,831
12,474 New
12,474 $13,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $130M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.